Efficacy of dupilumab in patients with asthma stratified by a minimally important fractional exhaled nitric oxide reduction at week 2 of treatment

被引：0

作者：

Pavord, I. ^{[1
]}

Wechsler, M. ^{[2
]}

Busse, W. W. ^{[3
]}

Domingo, C. ^{[4
]}

Xia, C.

Gall, R. ^{[5
]}

Pandit-Abid, N. ^{[6
]}

Jacob-Nara, J. A. ^{[6
]}

Amr, R. ^{[5
]}

Rowe, P. J. ^{[6
]}

Deniz, Y. ^{[5
]}

机构：

[1] Univ Oxford, Oxford, England

[2] Natl Jewish Hlth, Denver, CO USA

[3] Univ Wisconsin, Sch Med & Publ Hlth, Madison, WI USA

[4] Autonomous Univ Barcelona, Corporacio Sanitaria Parc Tauli, Barcelona, Spain

[5] Regeneron Pharmaceut Inc, Tarrytown, NY USA

[6] Sanofi, Bridgewater, MA USA

来源：

ALLERGY | 2023年 / 78卷

关键词：

D O I：

暂无

中图分类号：

R392 [医学免疫学];

学科分类号：

100102 ;

摘要：

000332

引用

页码：183 / 183

页数：1

共 50 条

[1] Efficacy of Dupilumab in Patients With and Without a Minimally Important Reduction in Fractional Exhaled Nitric Oxide After 2 Weeks of Treatment
Pavord, I. D.
Wechsler, M. E.
Busse, W.
Domingo Ribas, C.
Xia, C.
Gall, R.
Pandit-Abid, N.
Jacob-Nara, J. A.
Radwan, A.
Rowe, P. J.
Deniz, Y. M.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2023, 207
[2] EFFICACY OF DUPILUMAB IN PATIENTS WITH ASTHMA WITH/WITHOUT SUBSTANTIAL REDUCTION IN FRACTIONAL EXHALED NITRIC OXIDE
Halpin, D.
Korn, S.
Matucci, A.
Bourdin, A.
Daizadeh, N.
Ortiz, B.
Djandji, M.
Deniz, Y.
Rowe, P.
ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2020, 125 (05) : S34 - S34
[3] Relation between reduction in fractional exhaled nitric oxide and efficacy in asthma patients treated with dupilumab
Pavord, I. D.
Deniz, Y.
Casale, T.
Corren, J.
Fitzgerald, M.
Daizadeh, N.
Jagerschmidt, A.
Dillon, M.
Gall, R.
Pandit-Abid, N.
Siddiqui, S.
Jacob-Nara, J. A.
Rowe, P. J.
Busse, W. W.
EUROPEAN RESPIRATORY JOURNAL, 2022, 60
[4] Relation Between Fractional Exhaled Nitric Oxide Reductions and Efficacy Outcomes in Patients with Asthma Treated with Dupilumab
Busse, W.
Pavord, I. D.
Deniz, Y.
Casale, T. B.
Wenzel, S. E.
Corren, J.
Fitzgerald, J. M.
Daizadeh, N.
Jagerschmidt, A.
Harel, S.
Ortiz, B.
Djandji, M.
Crikelair, N.
Jacob-Nara, J. A.
Rowe, P. J.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2022, 205
[5] Fractional exhaled nitric oxide and asthma treatment adherence
Butler, Claire A.
Heaney, Liam G.
CURRENT OPINION IN ALLERGY AND CLINICAL IMMUNOLOGY, 2021, 21 (01) : 59 - 64
[6] Fractional exhaled nitric oxide as a biomarker in patients with uncontrolled asthma
Busse, W.
Milger-Kneidinger, K.
Pavord, I
Wechsler, M.
Davila, I
Altincatal, A.
Hardin, M.
Soler, X.
Sacks, H.
Jacob-Nara, J.
Deniz, Y.
Rowe, P.
PNEUMOLOGIE, 2024, 78 : S6 - S7
[7] Fractional exhaled nitric oxide as a biomarker in patients with uncontrolled asthma
Busse, William
Pavord, Ian D.
Wechsler, Michael E.
Davila, Ignacio J.
Altincatal, Arman
Hardin, Megan
Soler, Xavier
Sacks, Harry
Jacob-Nara, Juby A.
Deniz, Yamo
Rowe, Paul J.
EUROPEAN RESPIRATORY JOURNAL, 2023, 62
[8] Prediction of Clinical Response to Dupilumab in Patients with Severe Asthma Using Fractional Exhaled Nitric Oxide Combined with Pulmonary Function Testing
Liu, Yi-Liang
Zhang, Yong
INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY, 2024, 185 (09) : 856 - 864
[9] DUPILUMAB IMPROVES ASTHMA CONTROL AND REDUCES FRACTIONAL EXHALED NITRIC OXIDE AND EXACERBATIONS WITH INHALED CORTICOSTEROID WITHDRAWAL: A PHASE 2 STUDY
Wechsler, Michael E.
Jackson, David
Rabe, Klaus F.
Pavord, Ian D.
Virchow, J. C.
Katial, Rohit
Israel, Elliot
Xia, Changming
Soliman, Mena
Pandit-Abid, Nami
Jacob-Nara, Juby A.
Sacks, Harry
Rowe, Paul J.
Deniz, Yamo
CHEST, 2024, 166 (04) : 4779A - 4796A
[10] STABILITY OF FRACTIONAL EXHALED NITRIC OXIDE LEVELS AS A BIOMARKER IN PATIENTS WITH UNCONTROLLED ASTHMA
Busse, W. W.
Pavord, I. D.
Wechsler, M. E.
Davila, I. J.
Altincatal, A.
Hardin, M.
Soler, X.
Sacks, H.
Jacob-Nara, J. A.
Deniz, Y.
Rowe, P. J.
THORAX, 2023, 78 (SUPPL_4) : A181 - A182

← 1 2 3 4 5 →